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MATERIALS AND METHODS 
 
Immunohistochemistry and imaging 
To verify the phenotype of cells and measure c-fos activity, rodents were anaesthetized with 65 
mg/kg sodium pentobarbital and transcardially perfused with ice-cold 4% paraformaldehyde 
(PFA) in PBS (pH 7.4). Brains were fixed overnight in 4% PFA and then equilibrated in 30% 
sucrose in PBS. 40 µm-thick coronal sections were cut on a freezing microtome and stored in 
cryoprotectant at 4ºC until processed for immunohistochemistry. Free-floating sections were 
washed in PBS and then incubated for 30 min in 0.3% Triton X-100 (Tx100) and 3% normal 
donkey serum (NDS). Slices were incubated overnight with primary antibody in 0.01% Tx100 
and 3% NDS (rabbit anti-cfos 1:500, rabbit anti-GFAP 1:500, mouse anti-MAP2 1:500, mouse 
anti-GAD67 1:500, rabbit anti-GABA 1:200, mouse anti-vGlut1 1:500, mouse anti-vGlut2 
1:500, mouse anti-CaMKIIα 1:200, mouse anti-S100β 1:250, rabbit anti-glutamate 1:200, 
chicken anti-tyrosine hydroxylase 1:500, and goat anti-choline acetyltransferase 1:200). Sections 
were then washed and incubated with secondary antibodies (1:1000) conjugated to FITC, Cy3 or 
Cy5 for 3 hrs at room temperature. Following a 20 min incubation with DAPI (1:50,000) 
sections were washed and mounted on microscope slides with PVA-DABCO. 
 
Confocal fluorescence images were acquired on a scanning laser microscope using a 
20X/0.70NA or a 40X/1.25NA oil immersion objective. To determine the volume of c-fos 
activation, serial stack images covering a depth of 20 µm through multiple medial-lateral, 
anterior-posterior and dorsal-ventral subthalamic sections were acquired using equivalent 
settings. The image analysis software calculated the number of c-fos positive cells per field by 
thresholding c-fos immunoreactivity above background levels and using the DAPI staining to 
delineate nuclei. To determine the rate of viral transduction we determined the percentage of 
CaMKIIα-immunoreactive neurons per 40X field that were also eNpHR-YFP positive in 
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multiple serial stack images of subthalamic sections. Large field images of entire slices were 
collected on a Leica MZ16FA stereomicroscope. 
 
Lentivirus production and transduction 
Lentiviral vectors carrying the genes used were constructed using standard cloning techniques. 
The CaMKIIα::eNpHR construct was produced by PCR amplification of the eNpHR-EYFP 
construct previously published (S1) and cloned in-frame into the AgeI and EcoRI restriction sites 
of a lentivirus carrying the CaMKIIα promoter. The CaMKIIα::ChR2 construct was produced by 
PCR amplification of the ChR2-mCherry construct and was also cloned in-frame into the AgeI 
and EcoRI restriction sites of a lentivirus carrying the CaMKIIα promoter. The GFAP::ChR2 
construct was produced by replacing the CaMKIIα promoter with the GFAP promoter in the 
CaMKIIα::ChR2-mCherry construct using the AgeI and PacI restriction enzyme sites. The maps 
for CaMKIIα::ChR2 and CaMKIIα::eNpHR are available online at www.optogenetics.org. 
 
High titer lentivirus (>109 pfu/mL) was then produced via calcium phosphate co-transfection of 
293FT cells with the lentiviral vector, pCMVΔR8.74 and pMD2.G (S2). 24 h post-transfection, 
293FT cells were switched to serum-free medium containing 5 mM sodium butyrate; the 
supernatant was collected 16 h later and concentrated by ultracentrifugation at 50,000 × g with 
20% sucrose cushion. The resulting viral pellet was resuspended in phosphate buffered saline at 
1/1000th of the original volume. 
 
Adeno-associated virus production and transduction 
To ensure that there would be no significant expression leak in non-targeted cell types, we 
employed a Cre-inducible AAV vector with a double-floxed inverted open reading frame (ORF), 
wherein the ChR2-EYFP sequence is present in the antisense orientation. Upon transduction, 
Cre-expressing cells invert the ChR2-EYFP ORF in a stable, irreversible fashion and thereby 
activate sustained ChR2-EYFP expression under control of the strong and constitutively active 
elongation factor 1α (EF-1α) promoter (Feng Zhang, unpublished results). To construct Cre-
activated recombinant AAV vectors, the DNA cassette carrying two pairs of incompatible lox 
sites (loxP and lox2722) was synthesized and the ChR2-EYFP transgene was inserted between 
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the loxP and lox2722 sites in the reverse orientation. The resulting double-floxed reverse ChR2-
EYFP cassette was cloned into a modified version of the pAAV2-MCS vector carrying the EF-
1α promoter and the Woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) 
to enhance expression. The recombinant AAV vectors were serotyped with AAV5 coat proteins 
and packaged by the viral vector core at the University of North Carolina. The final viral 
concentration was 2 x 1012 genome copies (gc) / mL. 
 
Stereotactic injection and cannula placement 
Adult rats (female Fisher, 200–300 g) and mice (male and female, C57BL/6 background, 15–30 
g) were the subjects of these experiments. Animal husbandry and all aspects of experimental 
manipulation of our animals were in strict accord with guidelines from the National Institute of 
Health and have been approved by members of the Stanford Institutional Animal Care and Use 
Committee. All surgeries were performed under aseptic conditions. Rodents were anaesthetized 
using 1.5% isoflurane (for surgeries longer than 1 hr) or i.p. injection (90 mg/kg ketamine and 
5mg/kg xylazine for rats; 80 mg/kg and 15-20 mg/kg, respectively, for mice). The top of the 
animal’s head was shaved, cleaned with 70% ethanol and betadine and then placed in a 
stereotactic apparatus. Ophthalmic ointment was applied to prevent eye drying. A midline scalp 
incision was made and then small craniotomies were performed using a drill mounted on the 
stereotactic apparatus for the 6-OHDA injection in the medial forebrain bundle (rat: -2 AP, 2 
ML, -7.5 DV; mouse: -1.2 AP, 1.2 ML, -4.75 DV) and virus injection in the STN (rat: -3.6 mm 
AP, 2.5 mm ML; mouse: -1.9 mm AP, 1.7 mm ML). 
 
For rodents that were injected with lentivirus in the STN, in vivo extracellular recording was 
used to accurately determine the location of the STN along the dorsal-ventral axis. The depth 
was around -7 mm in rats and -4 mm in mice. The concentrated lentivirus (described above) was 
delivered to the STN using a 10µl syringe and a thin 34 gauge metal needle; the injection volume 
and flow rate (3 sites within the STN along the dorsal-ventral axis; each injection was 0.6 µl at 
0.1 µl/min) was controlled with an injection pump. After the final injection, the needle was left 
in place for 10 additional minutes and then slowly withdrawn. 
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6-OHDA was then used to lesion the substantia nigra and produce hemi-Parkinsonian rodents. 
Desipramine (20mg/kg for rats; 10 mg/kg for mice; noradrenergic reuptake inhibitor to prevent 
damage to noradrenergic terminals) was administered, followed ~30 minutes later by 6-OHDA 
(8 μg/4 μl for rats; 6 μg/2 μl for mice) with 0.1% ascorbic acid (to prevent degradation of 6-
OHDA) into the right medial forebrain bundle (rat: –2 AP , +2 ML, and -7.5 DV; mouse: -1.2 
AP, +1.2 ML, and -4.75 DV). The perfusion for the 6-OHDA injection (rat: 4 μl, mouse 2 μl) 
was at the rate of 1.2 μl/min for 4 min, and the needle was left in situ for an additional 5 minutes. 
 
A fiber guide (rat: C312G, mouse: C313G) was beveled to form a sharp edge (to more easily 
penetrate brain tissue and reduce tissue movement), and then inserted through the craniotomy to 
a depth of approximately 400 µm above the STN or the anterior primary motor cortex (mouse: 2 
AP, 2 ML, 0.5 DV). One layer of adhesive cement followed by cranioplastic cement was used to 
secure the fiber guide system to the skull. After 20 min, the scalp was sealed back using tissue 
adhesive. The animal was kept on a heating pad until it recovered from anesthesia. 
Buprenorphine (0.03 mg/kg) was given subcutaneously following the surgical procedure to 
minimize discomfort. A dummy cannula (rat: C312G, mouse: C313G) was inserted to keep the 
fiber guide patent. 
 
For electrical DBS control rodents, a stimulation electrode (MS303/3-B) was implanted in the 
STN. The procedure above was followed for OHDA injection, in vivo extracellular recording 
was then used to determine the depth of the STN, and the stimulation electrode was inserted to 
that depth and secured using one layer of adhesive cement followed by cranioplastic cement. 
Tissue adhesive was used to reseal the scalp, the animal was kept on a heating pad until recovery 
from anesthesia and buprenorphine was given to minimize discomfort. A dust cap (303DC/1) 
was then used to cover the electrode contacts. 
 
In vivo optrode recordings 
Simultaneous optical stimulation and electrical recording in a single region in living rodents was 
done as described previously (S3) using an optrode composed of an extracellular tungsten 
electrode (1 MΩ, ~125 µm) tightly attached to an optical fiber (~200 µm) with the tip of the 
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electrode deeper (~0.4 mm) than the tip of the fiber, to ensure illumination of the recorded 
neurons. For stimulation and recording in two distinct regions, small craniotomies were created 
above both target regions, and a fiber or optrode was placed above one region through one 
craniotomy and a plain electrode or optrode was placed in the other region through a separate 
craniotomy (see Fig. 6B for diagram; the picture is modified from The Jackson Laboratory 
website: http://jaxmice.jax.org/support/Thy1-ChR2-9_WholeBrain4x.pdf). Stimulation in the 
anterior motor cortex was achieved by placing the optical fiber just above the brain surface, 
activating layer 5 of the cortex; for STN stimulation, the fiber was 300 µm above the STN. The 
STN was identified using its highly stereotyped firing pattern and the fact that it is surrounded 
dorso-ventrally by silent regions. The optical fiber was coupled to a 473 nm or 561 nm laser 
diode (30 mW fiber output) from CrystaLaser. Single unit recordings were done in rats 
anesthetized with 1.5% isoflurane and mice anesthetized with intraperitoneal injections of 
ketamine (80 mg/kg)/xylazine (15-20 mg/kg) cocktail. pClamp 10 and a Digidata 1322A board 
were used to both collect data and generate light pulses through the fiber. The recorded signal 
was band pass filtered at 300Hz low/5 kHz high (1800 Microelectrode AC Amplifier). For 
precise placement of the fiber/electrode pair, stereotactic instrumentation was used.  
 
Behavior 
For behavior, multimode optical fibers (NA 0.37; rat: 400 µm core, BFL37-400; mouse: 300 µm 
core, BFL37-300) were precisely cut to the optimal length for maximizing the volume of the 
STN receiving light. About one week before behavior, an extracellular recording electrode was 
used to determine the depth of the dorsal border of the STN from the tip of the cannula guide and 
fibers were cut to be 200-300 µm shorter. For anterior motor cortex stimulation, the fiber was 
placed above layer 5 (less than a millimeter deep). To ensure stability of the fiber during testing 
in moving animals, an internal cannula adapter was glued to the stripped optical fiber. To insert 
the fiber, rodents were briefly placed under isoflurane and the fiber was inserted while the animal 
was recovering from anesthesia. The internal cannula adapter snapped onto the cannula guide 
and the bottom half of the plastic portion of a dummy cannula was also used to ensure the 
adapter remained connected to the top of the cannula guide (S3, S4). 
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For optical stimulation, the fiber was connected to a 473 nm or 561 nm laser diode (20 mW fiber 
output) through an FC/PC adapter. Laser output was controlled using a function generator 
(33220A) to vary the frequency, duty cycle, and intensity. For Thy1::ChR2 animals, the average 
minimum intensity used to produce therapeutic behavior was 10 mW. A custom aluminum 
rotating optical commutator (S3, S4) was used to release torsion in the fiber caused by the 
animal’s rotation. 
 
Motor behavior was assessed using amphetamine-induced rotations, head position bias, 
climbing, and track length. Animals were accepted for experimental investigation only if 
amphetamine reliably induced rotations in the ipsilateral direction confirming a 6-OHDA lesion 
of the substantia nigra. Before and after each stimulation trial, a trial of equal length with the 
light off was used as a control. Each of these trials was about 3 minutes long making the entire 
off-on-off sequence 9 minutes long. For amphetamine-induced behavior, amphetamine (rat: 2 
mg/kg; mouse: 2.6 mg/kg) was injected 30 minutes before behavioral measurements; the fiber 
was inserted into the cannula and the rodent placed in an opaque, non-reflective cylinder (rat: 
diameter 25 cm, height 61 cm; mouse: diameter 20 cm, height 46 cm) 10 minutes before the 
behavioral experiments. Rotations ipsilateral to the 6-OHDA lesions (clockwise turns) were 
counted, and contralateral rotations were subtracted. The percentage change calculation 
considered the change in rotational bias relative to the period without stimulation. Head position 
bias was determined by counting the number of head tilts (>10º deviation left or right of midline) 
over time. Each time the rodent rose up and touched either paw to the wall of the cylinder was 
counted as an instance of climbing. Track length was measured with Viewer. After the 
completion of behavior experiments, cannula placement was confirmed by slicing. 
 
For experiments where optical stimulation did not produce a change in the rodent behavior, we 
also collected path length and head position bias data while the rodents were under 
amphetamine. Continuous 561nm illumination of the STN expressing CaMKIIα::eNpHR-EYFP 
in 6-OHDA rats did not affect path length (cm/min; light on vs. light off: 757.05 ± 163.11 vs. 
785.74 ± 157.56, p = 0.90, n = 4 rats; mean ± s.e.m; 2-sample t-test) or head position bias (% of 
time to the right; light on vs. light off: 99.92 ± 0.08 vs. 99.75 ± 0.25, p = 0.56, n = 4 rats; mean ± 
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s.e.m; 2-sample t-test). Optical HFS (120 Hz, 5 ms pulse width) or LFS (20 Hz, 5 ms pulse 
width) of the STN expressing CaMKIIα::ChR2-mCherry in 6-OHDA rats did not affect path 
length (cm/min; HFS vs. light off: 803.82 ± 129.04 vs. 851.95 ± 166.20, p = 0.83, n = 5 rats; LFS 
vs. light off: 847.15 ± 141.95 vs. 779.11 ± 104.01, p = 0.74, n = 2 rats; mean ± s.e.m; 2-sample t-
test) or head position bias (% of time to the right; HFS vs. light off: 93.97 ± 3.78 vs. 94.20 ± 
2.96, p = 0.96, n = 5 rats; LFS vs. light off: 98.50 ± 1.50 vs. 98.50 ± 0.50, p = 1.00, n = 2 rats; 
mean ± s.e.m; 2-sample t-test). 473nm illumination of the STN expressing GFAP::ChR2-
mCherry in 6-OHDA rats also did not affect path length (cm/min; light on vs. light off: 1042.52 
± 113.73 vs. 1025.47 ± 113.63, p = 0.92, n = 4 rats; mean ± s.e.m; 2-sample t-test) or head 
position bias (% of time to the right; light on vs. light off: 98.16 ± 0.98 vs. 98.98 ± 0.65, p = 
0.52, n = 4 rats; mean ± s.e.m; 2-sample t-test). 
 
Optical Intensity Measurements 
Light transmission measurements were conducted with blocks of brain tissue prepared from two 
300 g Fisher rats and immediately tested. Blocks of tissue 2 mm in thickness were cut in 0–4 ºC 
sucrose solution using a vibratome. The tissue was then placed in a Petri dish containing the 
same sucrose solution over the photodetector of a power meter. The tip of a 200 μm diameter 
optical fiber coupled to a blue or yellow diode laser (473 nm or 561 nm, 30 mW fiber output) 
was mounted on a micromanipulator. First, the power was measured through the solution. Then, 
the tip of the fiber was moved down into the tissue in 100 µm increments and the power was 
measured. When the fiber reached the Petri dish, the power measured was compared to the initial 
measurement through the solution to confirm the total power output through the fiber. The 
percent transmission fraction was then calculated as the ratio between the power measured 
through tissue and the power measured through solution. The power intensity was then 
calculated by considering the light intensity spread due to the conical shape of the 30 mW light 
output from a 400 µm fiber based on the fiber’s numerical aperture of 0.37 (S5). The fiber output 
was assumed to be uniform across the diameter of the cone. Measurements were made through 
grey matter in three blocks of brain tissue for each wavelength with one block each moving 
anterior-posterior in the thalamus and in the cortex and dorsal-ventral through the thalamus. 
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Analysis of Electrophysiological Data 
Threshold search in Clampfit was used for automated detection of spikes in the multi-unit 
recording, which was then validated by visual inspection; the spike waveforms displayed by 
Clampfit were observed to check the quality of spike detection. For traces with multiple spike 
populations, thresholds were set to capture all the spikes; during bursting, it is likely that 
multiple neurons were recorded from simultaneously. Bursts were identified in Clampfit; any 
two consecutive spikes occurring in an interval less than 300 ms were counted as belonging to 
the same burst and only bursts of at least 3 spikes were included. To quantify the neural activity 
at different frequencies, spectra for in vivo extracellular recording traces were generated using a 
wavelet transform after converting the traces into binary spike trains. The trace was then 
converted into a histogram with a binwidth of 0.5 ms for each of the duration-matched pre-
stimulation, stimulation, and post-stimulation epochs. The start and end times for each of the 
segments, as well as the number of spikes, are listed below. 
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 Pre Stimulation Light On Post Stimulation
  Start End Spikes Start End Spikes Start End Spikes
Fig 1 
(CaMKIIα::eNpHR) 
32.5 72.5 413 102.5 142.5 84 175 215 435 
Fig 3 
(CaMKIIα::ChR2, 
HFS) 
5.28 10.4 238 15.38 20.5 477 22.48 27.6 235 
Fig 5 
(Thy1::ChR2,HFS) 
0 10.62 90 14.98 25.6 0 29.38 40 94 
Fig 5 (Thy1::ChR2, 
LFS) 
0 10.62 139 14.98 25.6 383 29.38 40 132 
Fig 6 (Thy1, HFS 
M1, M1 recd) 
0.8 4.8 55 15.46 19.46 28 26 30 30 
Fig 6 (Thy1, HFS 
M1, STN recd) 
0.94 5.4 19 15 19.46 37 25.54 30 16 
Fig 6 (Thy1, LFS 
M1, M1 recd) 
0 5.5 131 18.5 24 313 30.5 36 64 
Fig 6 (Thy1, LFS 
M1, STN recd) 
0 5.5 50 18.5 24 115 30.5 36 39 
Fig S4 (eNpHR, 
small unit) 
32.5 72.5 263 102.5 142.5 84 175 215 248 
Fig S4 (eNpHR, 
large unit) 
32.5 72.5 114 102.5 142.5 0 175 215 145 
Table S1. The three segments of each power spectra were time matched; this table shows 
the segments of each trace (the start and end time in seconds), as well as the number of 
spikes detected during each period. Time intervals were chosen to reflect stationary states 
before, during, and after stimulation for each trace, to account for temporal delays in 
onset or offset of physiological effects.
The spike histograms were then convolved with a wavelet to measure the amplitude of the 
spectra at frequencies below 150 Hz over time. The average amplitude over time for each 
frequency was then plotted. The wavelet used is reproduced below. 
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For determining the change in activity of multiple frequency bands, amplitude spectra for 
multiple duration-matched baseline and stimulation sweeps were calculated as described above. 
Mean amplitude within each frequency band was determined and the ratio of this value 
(stimulation/baseline) was calculated. Spike latencies of the M1 response to optical stimulation 
of the STN were determined by measuring the delay between the first peaks in simultaneous 
optrode recordings of M1 and STN of a Thy1::ChR2-EYFP 6-OHDA mouse. 20 Hz, 5 ms pulse 
width of 473nm light was used to activate the STN. 
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SUPPLEMENTARY FIGURES 
 
Fig. S1: Substantia nigra lesion and cannula track. Loss of nigral dopaminergic cells following 
6-OHDA administration in rat (A) and mouse (B): coronal slices (rat: AP -5.8; mouse AP -3) 
show decreased tyrosine hydroxylase levels (red) unilaterally in the substantia nigra pars 
compacta; SNc is outlined by white brackets. Insets below show higher resolution images of the 
lesioned (left) and unlesioned (right) sides of the substantia nigra. (C) Cannula track is visible in 
a coronal slice showing correct placement of the cannula above the STN area. 
 
Fig. S2: Additional histological characterization. (A) STN cells expressing CaMKIIα::eNpHR-
EYFP (green) label for the excitatory neuron specific glutamate marker (red). (B) STN cells 
expressing GFAP::ChR2-mCherry (red) costain with the astroglia-specific marker S100β 
(green). In both (A) and (B) yellow indicates colocalization of the two markers. (C) 
Representative confocal images of TH stain for dopamine (top) and CHAT stain for 
acetylcholine (bottom) showed no colocalization with Thy1::ChR2-EYFP expression in the STN. 
 
Fig. S3: Additional behavioral results. (A) Continuous 473nm illumination of the STN 
expressing GFAP::ChR2-mCherry in an anesthetized 6-OHDA mouse completely inhibited STN 
activity. (B) and (C): Extension of mouse results. (B) Amphetamine-induced rotations were not 
affected by 50% duty cycle illumination of the GFAP::ChR2 expressing STN in 6-OHDA mice 
(n = 1 mouse and 2 sessions). (C) Amphetamine-induced rotations were not affected by high 
(130 Hz, 5ms pulse width, n = 1 mouse and 2 sessions) or low (20 Hz, 5ms, n = 1 mouse and 1 
session) frequency optical stimulation in the CaMKIIα::ChR2 expressing STN in 6-OHDA mice. 
(D) and (C): Modulation of inhibitory neurons during behavior. Although mainly excitatory, 
STN has about 7-10% percent cells that stain for inhibitory neuronal markers, such as GAD65/67 
and parvalbumin (Allen Brain Atlas). To obtain specific expression in either GAD67 or 
parvalbumin neurons we injected GAD67-Cre and parvalbumin-Cre mice respectively (gift of 
Sylvia Arber) with a Cre-inducible adeno-associated virus (AAV) vector carrying ChR2-EYFP 
(Methods). Cre-dependent opsin expression was observed in the STN region, but behavior was 
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unchanged with optical stimulation. (D) Amphetamine-induced rotations were not affected by 
high (130 Hz, 5ms, n = 2 mice and 4 sessions) or low (20 Hz, 5ms, n = 1 mouse and 2 sessions) 
frequency optical stimulation in 6-OHDA GAD67-Cre mice. (E) Amphetamine-induced 
rotations were not affected by high (130 Hz, 5ms, n = 2 mice and 2 sessions) or low (20 Hz, 5ms, 
n = 2 mice and 2 sessions) frequency optical stimulation in 6-OHDA parvalbumin-Cre mice.  
 
Fig. S4: Additional electrophysiological results. Isolation of large amplitude (A) and small 
amplitude (B) units from the trace in Fig. 1C and corresponding power spectra. Red lines 
represent average waveforms for all superimposed spikes that occurred during 70s of baseline 
activity (n = 205 spikes for large amplitude unit and n = 428 spikes for small amplitude unit). 
Both small and large amplitude units showed decreased activity during light that returned to 
normal baseline levels after stimulation. (C) Response of STN to optical stimulation of STN in a 
Thy1::ChR2-EYFP 6-OHDA mouse at 90Hz. The STN is initially excited but activity is reduced 
in the emergent stationary state measured by loss of the large amplitude spikes evident during the 
baseline; nevertheless, significant low amplitude activity persists throughout the stimulation.  (D) 
High-temporal resolution trace of the STN response to optical stimulation of STN in a 
Thy1::ChR2-EYFP 6-OHDA mouse at 130Hz (see Fig. 5B for full trace). Again, the STN 
initially responds with a spike followed by low amplitude activity throughout stimulation.  
Changes in amplitude of the local circuit responses can reflect either altered recruited cell 
number or altered excitability of recruited cellular elements. While optrode recordings cannot 
report on the precise cell types involved in generating activity, by eliminating the electrical 
stimulation artifact these recordings provide a window into the amplitude and timing properties 
of local circuit electrical responses arising from local excitatory or inhibitory cell types and 
fibers in the STN region that could not be achieved with electrical stimulation.  
 
Fig. S5: High-temporal resolution optrode traces. (A) Single unit activity in CaMKIIα::eNpHR-
EYFP expressing STN with continuous 561 nm light illumination in an anesthetized 6-OHDA rat 
(corresponding to trace in Fig. 1C). (B) Neuronal activity in CaMKIIα::ChR2-mCherry 
expressing STN with high frequency optical stimulation (120 Hz, 5 ms pulse width, 473 nm) in 
an anesthetized 6-OHDA rat (corresponding to trace in Fig. 3B). (C) and (D) Activity in the STN 
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region in an anesthetized Thy1::ChR2-EYFP 6-OHDA mouse in response to high (HFS, 130 Hz, 
5 ms) and low (LFS, 20 Hz, 5 ms) frequency optical stimulation using 473 nm light. Note the 
low amplitude of activity in the HFS trace (corresponding to trace in Fig. 5B). 
 
Fig. S6: Latency of M1 response to optical stimulation of STN. (A) Response of M1 Layer 5 
(L5) to optical stimulation of STN in the Thy1::ChR2-EYFP 6-OHDA mouse at 20Hz, 5ms 
pulse width. (B) While stimulating STN with light, simultaneous recordings of light-induced 
activity in the STN (top trace) and M1/L5 (bottom trace) revealed short latency differences 
between the first peaks consistent with antidromic spiking. (C) Individual latency differences 
between the first peak in STN and M1/L5 for 16 stimulation bouts revealed minimal jitter (S.D. 
= 0.032 ms) consistent with antidromic spiking in the well-known M1-STN projection. 
 
Fig. S7: Changes in frequency characteristics of neuronal activity produced by optical 
stimulation. (A) Activity in all frequency bands was reduced by continuous 561nm illumination 
of the STN expressing CaMKIIα::eNpHR-EYFP in anesthetized 6-OHDA rats (n = 5 sweeps). 
Frequency bands are defined as: delta 1-3 Hz; theta 4-8 Hz; alpha 9-12 Hz; beta 13-30 Hz; 
gamma 31-80 Hz; high frequency (HF) 81-130 Hz. (B) Optical HFS (120 Hz, 5 ms pulse width) 
of the STN expressing CaMKIIα::ChR2-mCherry in 6-OHDA rats reduced activity for 
frequencies between 4 and 80 Hz, while increasing activity in the HF band (n = 3). (C) Activity 
change in M1 (left, n = 4) and STN (right, n = 4) produced by optical HFS (130 Hz, 5 ms) 
stimulation of M1 in 6-OHDA Thy1::ChR2 mice. Delta activity in both M1 and STN was 
reduced. (D) Activity change in M1 (left, n = 4) and STN (right, n = 4) produced by optical LFS 
(20 Hz, 5 ms) stimulation of M1 in 6-OHDA Thy1::ChR2 mice. Beta, gamma, and HF activity in 
both M1 and STN was increased. (E) Optical LFS (20 Hz, 5 ms) of the STN in 6-OHDA 
Thy1::ChR2 mice increased activity in the beta, gamma, and HF bands (n = 3).  (F) Spike counts 
for duration-matched baseline and optical stimulation segments for each experiment type. 
Optical stimulation of the STN expressing CaMKIIα::GFAP-mCherry and optical HFS in 6-
OHDA Thy1::ChR2 mice abolished spiking activity, reducing activity across all frequencies to 
zero (not shown). Error bars are s.e.m.; t-test with µ = 100 used for statistics, * p < 0.05. 
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